|
1
|
Kessler RC, Berglund P, Demler O, et al:
The epidemiology of major depressive disorder: results from the
National Comorbidity Survey Replication (NCS-R). JAMA.
289:3095–3105. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Berton O and Nestler EJ: New approaches to
antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci.
7:137–151. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Uppal A, Singh A, Gahtori P, Ghosh SK and
Ahmad MZ: Antidepressants: current strategies and future
opportunities. Curr Pharm Des. 16:4243–4253. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mitchell AJ: Two-week delay in onset of
action of antidepressants: new evidence. Br J Psychiatry.
188:105–106. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wright CE, Strike PC, Brydon L and Steptoe
A: Acute inflammation and negative mood: mediation by cytokine
activation. Brain Behav Immun. 19:345–350. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dantzer R: Cytokine-induced sickness
behavior: mechanisms and implications. Ann NY Acad Sci.
933:222–234. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pollak Y and Yirmiya R: Cytokine-induced
changes in mood and behaviour: implications for ‘depression due to
a general medical condition’, immunotherapy and antidepressive
treatment. Int J Neuropsychopharmacol. 5:389–399. 2002.
|
|
8
|
Skolnick P, Popik P and Trullas R:
Glutamate-based antidepressants: 20 years on. Trends Pharmacol Sci.
30:563–569. 2009.PubMed/NCBI
|
|
9
|
Machado-Vieira R, Salvadore G,
Diazgranados N and Zarate CA Jr: Ketamine and the next generation
of antidepressants with a rapid onset of action. Pharmacol Ther.
123:143–150. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dale O, Somogyi AA, Li Y, Sullivan T and
Shavit Y: Does intra-operative ketamine attenuate inflammatory
reactivity following surgery? A systematic review and
meta-analysis. Anesth Analg. 115:934–943. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ward JL, Harting MT, Cox CS Jr and Mercer
DW: Effects of ketamine on endotoxin and traumatic brain injury
induced cytokine production in the rat. J Trauma. 70:1471–1479.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takahashi T, Kinoshita M, Shono S, et al:
The effect of ketamine anesthesia on the immune function of mice
with postoperative septicemia. Anesth Analg. 111:1051–1058.
2010.PubMed/NCBI
|
|
13
|
Yang C, Hu YM, Zhou ZQ, Zhang GF and Yang
JJ: Acute administration of ketamine in rats increases hippocampal
BDNF and mTOR levels during forced swimming test. Ups J Med Sci.
Sep 13–2012.(Epub ahead of print).
|
|
14
|
Busch CJ, Spöhr FA, Motsch J, Gebhard MM,
Martin EO and Weimann J: Effects of ketamine on hypoxic pulmonary
vasoconstriction in the isolated perfused lungs of endotoxaemic
mice. Eur J Anaesthesiol. 27:61–66. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nakayama M and Murray PA: Ketamine
preserves and propofol potentiates hypoxic pulmonary
vasoconstriction compared with the conscious state in chronically
instrumented dogs. Anesthesiology. 91:760–771. 1999. View Article : Google Scholar
|
|
16
|
Taniguchi T and Yamamoto K:
Anti-inflammatory effects of intravenous anesthetics on
endotoxemia. Mini Rev Med Chem. 5:241–245. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun J, Zhou ZQ, Lv R, Li WY and Xu JG:
Ketamine inhibits LPS-induced calcium elevation and NF-kappa B
activation in monocytes. Inflamm Res. 53:304–308. 2004.PubMed/NCBI
|
|
18
|
Raedler TJ: Inflammatory mechanisms in
major depressive disorder. Curr Opin Psychiatry. 24:519–525.
2011.PubMed/NCBI
|
|
19
|
Hannestad J, DellaGioia N and Bloch M: The
effect of antidepressant medication treatment on serum levels of
inflammatory cytokines: a meta-analysis. Neuropsychopharmacology.
36:2452–2459. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Catena-Dell’Osso M, Bellantuono C, Consoli
G, Baroni S, Rotella F and Marazziti D: Inflammatory and
neurodegenerative pathways in depression: a new avenue for
antidepressant development? Curr Med Chem. 18:245–255.
2011.PubMed/NCBI
|
|
21
|
Song C and Wang H: Cytokines mediated
inflammation and decreased neurogenesis in animal models of
depression. Prog Neuropsychopharmacol Biol Psychiatry. 35:760–768.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Owen BM, Eccleston D, Ferrier IN and Young
AH: Raised levels of plasma interleukin-1beta in major and
postviral depression. Acta Psychiatr Scand. 103:226–228. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Piletz JE, Halaris A, Iqbal O, et al:
Pro-inflammatory biomakers in depression: treatment with
venlafaxine. World J Biol Psychiatry. 10:313–323. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brambilla F, Monteleone P and Maj M:
Interleukin-1beta and tumor necrosis factor-alpha in children with
major depressive disorder or dysthymia. J Affect Disord.
78:273–277. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Castanon N, Bluthe RM and Dantzer R:
Chronic treatment with the atypical antidepressant tianeptine
attenuates sickness behavior induced by peripheral but not central
lipopolysaccharide and interleukin-1beta in the rat.
Psychopharmacology (Berl). 154:50–60. 2001. View Article : Google Scholar
|
|
26
|
Merali Z, Brennan K, Brau P and Anisman H:
Dissociating anorexia and anhedonia elicited by interleukin-1beta:
anti-depressant and gender effects on responding for ‘free chow’
and ‘earned’ sucrose intake. Psychopharmacology (Berl).
165:413–418. 2003.PubMed/NCBI
|
